Credo Introduces a Digital Companion for Managing Chronic Conditions

The digital companion provides assistance in managing chronic conditions such as diabetes and heart ailments

Credo Health Services, a digital therapeutics company, has recently unveiled its digital companion platform for managing chronic conditions. The launch event, held in Bengaluru, was attended by the company's leadership team.

The digital companion platform provided by Credo Health supports chronic conditions such as diabetes, heart disease, hypertension, and chronic kidney disease. It incorporates personalized treatment plans that leverage digital tools like mobile apps, wearables, and telemedicine. The company's goal is to empower patients to take control of their health and achieve improved health outcomes.

India grapples with a significant burden of chronic diseases, including diabetes, cardiovascular diseases, kidney disease, respiratory diseases, cancer, and neurological disorders. Cardiovascular disease is the leading cause of death in the country and with approximately 77 million diabetic patients at high risk of cardiac issues, the need for effective chronic condition management is crucial. Credo Health aims to address this need through its digital companion platform.

The founders and healthcare professionals associated with Credo Health express enthusiasm for the potential for digital therapeutics to revolutionize healthcare. They emphasize the importance of patient empowerment through knowledge, data, and artificial intelligence in driving positive healthcare outcomes. The platform enables personalized care for diabetes management, incorporating features such as blood sugar monitoring, nutrition guidance, exercise tracking, and vital parameter monitoring.

With the COVID-19 pandemic highlighting the need for remote care solutions, Credo Health's AI-based precision care technology is positioned to address the growing demand for digital healthcare solutions from the comfort of patients' homes or workplaces.